Navigation Links
Blood Pressure Drugs Might Prevent Parkinson's
Date:2/6/2008

Preliminary study finds some benefit from calcium channel blockers

WEDNESDAY, Feb. 6 (HealthDay News) -- People taking calcium channel blockers to control their high blood pressure may find the regimen has a double benefit: Researchers say long-term use of the drugs also might cut the risk of developing Parkinson's disease.

But the findings are far from definitive and not yet ready for prime-time medical practice.

"There are not necessarily direct clinical implications, but the data support previous hypotheses that calcium channel blockers may have neuroprotective effects," said study senior author Christoph R. Meier, a clinical pharmacologist with University Hospital Basel, in Switzerland. "This may stimulate additional clinical and mainly basic research in this area."

The findings were published in the Feb. 6 online issue of Neurology, the medical journal of the American Academy of Neurology.

Parkinson's disease is a chronic, degenerative neurological disorder affecting at least one million people in the United States and six million people worldwide, according to the Michael J. Fox Foundation for Parkinson's Research. The condition involves the loss of brain cells that produce the chemical dopamine, resulting in movement problems including tremors.

Previous studies with rodents and primates had uncovered a possible "neuroprotective effect" from calcium channel blockers and angiotensin converting enzyme (ACE) inhibitors, another class of blood pressure medications, the researchers said.

The new study looked at the effect of calcium channel blockers, ACE inhibitors, AT II antagonists and beta blockers on the development of Parkinson's disease.

The study involved more than 7,000 men and women in the United Kingdom over the age of 40, half of whom had been diagnosed with Parkinson's and half of whom had not. Almost half the people in each group used blood pressure medications.

Participants currently taking calcium channel blockers lowered their risk of developing Parkinson's by 23 percent. There was no real effect for the other types of medications.

The strongest reduction in risk was seen in patients who had had 30 or more prescriptions filled and were still receiving prescriptions within 90 days prior to the diagnosis of Parkinson's, the researchers said.

Women tended to have more of a risk reduction than men but not if they had had less than 30 prescriptions filled. Individuals over the age of 80 had the most pronounced lowering of risk.

But even the study authors acknowledged that it's not clear where to go next with the findings.

"It may be desirable that basic research activities explore the effect of calcium channel blockers on the central nervous system which may lead (in theory) to new therapeutic strategies or even new drugs to prevent or treat Parkinson's," Meier said. "Regarding clinical or epidemiological/observational research, it would be nice if other research groups analyzed their databases and came up with their findings. They may either confirm our observations or come to the conclusion that our finding is isolated and that there is no need to further pursue this issue."

Dr. Ralph Sacco, professor and chair of neurology at the University of Miami Miller School of Medicine, agreed. "This is a tricky one. You don't know if there is a true association or not. There are potential problems with this type of analysis," he said.

But, Sacco pointed out, there is evidence accumulating on the relationship between Alzheimer's, another neurodegenerative disease, and circulatory system problems.

More information

Learn more about Parkinson's at the Michael J. Fox Foundation for Parkinson's Research.



SOURCES: Christoph R. Meier, Ph.D., clinical pharmacologist, Basel Pharmacoepidemiology Unit, Division of Clinical Pharmacology and Toxicology, University Hospital Basel, Basel, Switzerland; Ralph L. Sacco, M.D., professor and chair of neurology, University of Miami Miller School of Medicine; Feb. 6, 2008, Neurology, online


'/>"/>
Copyright©2008 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Intensive blood sugar treatment in trial of diabetes and cardiovascular disease changed
2. Dangerous Condition Underscores Importance of Home Blood Pressure Monitoring
3. Cord Blood America Supports Trend From New York, California for States to Inform Parents of the Advantages of Umbilical Cord Blood Storage
4. Novel small molecule therapy shows benefit for anemic patients via hydration of red blood cells
5. Research shows a daily does of beetroot juice can beat high blood pressure
6. Hospital Patients Blood Clot Risk High
7. Drug-based on MGH discovery may significantly improve treatment of dangerous blood disorder
8. Docs Should Tell All About Cord Blood Banks
9. Engineers use bloods hydrodynamics to manipulate stem, cancer cells
10. Genetics Influence Blood Pressure Medications
11. Liver Cancer Drug Raises Blood Pressure
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Blood Pressure Drugs Might Prevent Parkinson's
(Date:2/24/2017)... Farifax, VA (PRWEB) , ... February 24, 2017 , ... ... winners for excellence in radiology marketing programs at the annual Building Better ... the Worthington Renaissance Fort Worth Hotel in Fort Worth, Texas. Nine awards are given ...
(Date:2/24/2017)... , ... February 24, 2017 , ... ... into the Senior International Elite division on February 12th. Ms. Esparza qualified ... at the elite qualifier competition held in Las Vegas, Nevada. Frida is one ...
(Date:2/23/2017)... ... February 23, 2017 , ... Thinksport, the most award-winning sunscreen ... Fondo of Marin. For the second year in a row, cyclists will stay ... “We are thrilled to provide our safe, non-toxic sunscreen to over 2,000 cycling ...
(Date:2/23/2017)... ... February 23, 2017 , ... The 89th Academy Awards will be celebrated ... National Education Policy Center Bunkum Award. We invite you to enjoy our 11th annual ... Bunkum winner is the Center for American Progress (CAP), for its report, Lessons From ...
(Date:2/23/2017)... ... 23, 2017 , ... Rare Disease Report®, which is the ... Rare Disease Day events, hosted by the Rare Disease Legislative Advocates (RDLA) on ... weekly e-newsletter and quarterly publication, will be conducting interviews with patients and advocates ...
Breaking Medicine News(10 mins):
(Date:2/23/2017)... Südkorea, 23. Februar 2017 LG Innotek hat ... vorgestellt. Die Sterilisationsleistung beträgt das 1,5-fache des 45-mW-Moduls der ... im Bereich zwischen 200 und 280 nm und eignet sich ... indem es ihre DNA zerstört. Das Produkt von LG ... ...
(Date:2/23/2017)... -- Im Rahmen seiner Schlüsselwachstumsstrategie arbeitet die ... chinesischen Provinz Guizhou, 2017 mit dem Angebot von Anreize schaffenden ... Entwicklung einer eingebetteten Hightech-Schlüsselindustrie. Foto - http://mma.prnewswire.com/media/471342/First_CRH__CHina_Railway_High_Speed__Train_Enters_Guian.jpg ... ... ...
(Date:2/23/2017)... 2017 Obese people are seldom ... varicose veins in their body. The rising number of ... adoption of endovenous laser therapy for treatment of varicose ... therapy market, published by Future Market Insights, indicates ... consequences of obesity have collectively factored the growth in ...
Breaking Medicine Technology: